Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Vaccine|May 24, 2011
Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic miceSaifeng Wang, Lipeng Qiu, Guangze Liu, et al.
Plos One|May 17, 2016
Interaction of Toll-Like Receptors with the Molecular Chaperone Gp96 Is Essential for Its Activation of Cytotoxic T Lymphocyte ResponseWeiwei Liu, Mi Chen, Xinghui Li, et al.
The Journal of General Virology|June 18, 2019
A peptide-based inhibitor of gp96 suppresses HBsAg expression and HBV replication by upregulation of p53Liyuan Qian, Hongxia Fan, Ying Ju, et al.
Protein & Cell|April 12, 2014
Competitive virus and host RNAs: the interplay of a hidden virus and host interactionChangfei Li, Jun Hu, Junli Hao, et al.
Vaccine|February 12, 2013
Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunityCaiwei Chen, Jing Li, Yuhai Bi, et al.
Vaccine|November 15, 2012
TAT-mediated gp96 transduction to APCs enhances gp96-induced antiviral and antitumor T cell responsesBao Zhao, Yanzhong Wang, Yu Zhang, et al.
Antiviral Research|January 20, 2016
PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expressionXiaoyu Chu, Bo Wu, Hongxia Fan, et al.
Biochemical and Biophysical Research Communications|July 17, 2010
miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBVLipeng Qiu, Hongxia Fan, Wensong Jin, et al.
Cancer Letters|February 1, 2015
Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancerBo Wu, Xiaoyu Chu, Cong Feng, et al.
Vaccine|April 5, 2014
Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccineYing Ju, Hongxia Fan, Jun Liu, et al.
Pageof 8